🇺🇸 FDA
Patent

US 12252550

Antibodies that bind to C1S and uses thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 12252550 (Antibodies that bind to C1S and uses thereof) held by DIANTHUS THERAPEUTICS OPCO, INC. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DIANTHUS THERAPEUTICS OPCO, INC.
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61P, A61P7/00